We are live on
!
Find out more
IVLAV
Index Venture Life Associates VI Portfolio holdings
AUM
$396M
1-Year Est. Return
176.22%
This Fund
S&P 500
This Quarter
Est. Return
+4.7%
1 Year Est. Return
+176.22%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
–
Cap. Flow
+$165M
Cap. Flow
% of AUM
98.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$165M |
| 2 |
Century Therapeutics
IPSC
|
+$256K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
GPC
HBFP
EH
PIM
DI
TPWA
VC
FIG
Index Venture Life Associates VI's Q4 2024 Portfolio in Review
As of Q4 2024, Index Venture Life Associates VI held 2 positions worth $167M. Its ten largest holdings account for 100% of the portfolio.
Index Venture Life Associates VI deployed $165M of net new capital in Q4 2024, opening 2 new positions. Its largest new stake was Centessa Pharmaceuticals: 9,961,789 shares worth $167M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Index Venture Life Associates VI's largest Q4 2024 buy was Centessa Pharmaceuticals: 9,961,789 shares worth $167M.
- Index Venture Life Associates VI's ten largest holdings make up 100% of its $167M portfolio in Q4 2024.
- Index Venture Life Associates VI opened 2 new positions and closed 0 in Q4 2024.
Based on Index Venture Life Associates VI's 13F filing for Q4 2024, filed 14 Feb 2025.